Login to Your Account

Second Quarter Analysis

Biotechs Continue to Increase R&D Drug Discovery Spending

By Peter Winter

Tuesday, September 3, 2013

It is no secret that the price tag to develop and successfully bring a new therapy to the marketplace is on the rise. According to a variety of sources research and development (R&D) expenditures to achieve product approval success can, depending on the therapy, run as high as $1.3 billion.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription